tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BrainStorm Cell Therapeutics Reports Q2 2025 Progress
PremiumCompany AnnouncementsBrainStorm Cell Therapeutics Reports Q2 2025 Progress
5M ago
BrainStorm downgraded to Hold from Buy at Maxim
Premium
The Fly
BrainStorm downgraded to Hold from Buy at Maxim
6M ago
Brainstorm Cell Therapeutics Faces Nasdaq Delisting Notice
Premium
Company Announcements
Brainstorm Cell Therapeutics Faces Nasdaq Delisting Notice
6M ago
BrainStorm reports new survival data from EAP for NurOwn
PremiumThe FlyBrainStorm reports new survival data from EAP for NurOwn
7M ago
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
Premium
Ratings
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
8M ago
BrainStorm signs LOI with Minaris to manufacture NurOwn
Premium
The Fly
BrainStorm signs LOI with Minaris to manufacture NurOwn
8M ago
Brainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
PremiumCompany AnnouncementsBrainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
8M ago
One new option listing and nine option delistings on May 19th
Premium
The Fly
One new option listing and nine option delistings on May 19th
8M ago
BrainStorm receives FDA clearance to initiate Phase 3b clinical trial of NurOwn
Premium
The Fly
BrainStorm receives FDA clearance to initiate Phase 3b clinical trial of NurOwn
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100